The simultaneous termination of the ATM facility alongside this PIPE-like offering suggests the company needed immediate cash and is now fully reliant on this capital structure. Monitor the 90-day stockholder meeting for warrant exercise approval; if approval is delayed, the warrants remain unexercisable and the company may face further capital constraints. The 30-day lock-up expires 30 days after the effective date of the registration statement for the warrant shares.
Price Chart
Executive Summary
bioAffinity Technologies entered into a placement agency agreement and securities purchase agreement on October 8, 2026, to sell approximately $4 million of registered common stock (or pre-funded warrants) and unregistered common warrants to institutional investors through WallachBeth Capital. The offering is priced at $6.122 per share, with a concurrent private placement of warrants exercisable at the same price for 5 years post-stockholder approval. The company also filed a prospectus supplement reducing its ATM facility to zero, effectively closing that capital source. This capital raise, combined with the termination of the ATM, signals near-term cash needs and potential dilution of approximately 1.3 million shares (including warrant coverage).
Key Financial Metrics
Key Facts
- Total offering size of approximately $4,000,000 in registered and unregistered securities
- Pricing at $6.122 per share, with a concurrent private placement of warrants for up to 980,072 shares at $6.122 exercise price
- Common warrants exercisable for 5 years from stockholder approval date, representing 150% of shares/pre-funded warrants purchased
- Placement agent fees of 7.5% of gross proceeds plus up to $70,000 in expenses and 3% warrant coverage
- Company simultaneously filed Supplement No. 1 to ATM prospectus reducing available ATM sales to zero
- 30-day lock-up on further equity issuances; 6-month prohibition on variable rate transactions
- Stockholder approval required for warrant exercise; company must seek approval within 90 days and every 90 days thereafter
- Pre-funded warrants have $0.007 exercise price; beneficial ownership limitation of 4.99% (or 9.99% at purchaser election)
- Closing expected on or about October 9, 2026
Financial Impact
Approximately $4 million gross proceeds, net ~$3.63 million after placement agent fees and expenses. Dilution of up to 653,381 shares (or pre-funded warrants) plus 980,072 warrant shares, totaling ~1.63 million shares if fully exercised.
Risk Factors
- Dilution of approximately 1.63 million shares if all warrants are fully exercised
- Stockholder approval may not be obtained, delaying warrant exercise and potentially limiting capital access
- Termination of ATM removes a flexible capital source, increasing reliance on this single offering
- Market price may decline below the $6.122 exercise price, making warrants out-of-the-money and reducing incentive
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-046548 |
| Exhibit: ex10-1.htm | 0001493152-26-046548 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | DEF 14A | $2.83 | awaiting T+60 | — | $2.96 (+4.59%) |
Oct 15, 2026 12d ago | 8-K | $3.96 | awaiting T+60 | — | $2.96 (−25.25%) |
Oct 13, 2026 14d ago | 8-K | $3.63 | awaiting T+60 | — | $2.96 (−18.34%) |
Oct 9, 2026 18d ago | 8-K | $3.90 | awaiting T+60 | — | $2.96 (+24.10%) |
Oct 9, 2026 18d ago | 424B5 | $4.73 | awaiting T+60 | — | $2.96 (+37.35%) |
Oct 9, 2026 18d ago | 424B5 | $4.73 | awaiting T+60 | — | $2.96 (−37.35%) |
Oct 8, 2026 19d ago | 8-K | $5.64 | awaiting T+60 | — | $2.96 (−47.52%) |
Oct 6, 2026 21d ago | 8-K | $6.06 | awaiting T+60 | — | $2.96 (−51.16%) |
Sep 30, 2026 27d ago | 8-K | $6.56 | awaiting T+60 | — | $2.96 (−54.88%) |
Sep 22, 2026 5w ago | 8-K | $8.56 | awaiting T+60 | — | $2.96 (−65.40%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers